Newsroom
Featured News
- Investors10 September 2024
Lotus Reported Unaudited August Revenues of NT$1,325 million
- Business05 September 2024
Lotus acquires Alpha Choay® in Vietnam and Cambodia from Sanofi
- Investors12 August 2024
Lotus pharmaceutical 2Q24 earnings call
- Investors09 August 2024
Lotus Reported Unaudited July Revenues of NT$2,722 million, second-highest monthly revenue in the company's history
- Investors08 August 2024
Lotus announced 2Q24 financial results with robust QoQ and YoY growth
- Business26 July 2024
Lotus Pharmaceutical Honored 2024 Taiwan BIO Awards- Outstanding Company of the Year, Showcasing Excellence in Operational Performance, Development Strategy, and Technological Innovation
- Investors10 July 2024
Lotus Reported Unaudited June Revenues of NT$1,114 million
- Business05 July 2024
Lotus Pharmaceuticals Secures Three HR Asia Awards for 2024
- Investors07 June 2024
Lotus Reported Unaudited May Revenues of NT$1,553 million
